What is the average shipment value for India to Netherlands pharmaceutical trade?

$150.5K per consignment across 1,546 shipments.

How many Indian pharmaceutical companies export to Netherlands?

120 Indian companies. Largest: INTERVET INTERNATIONAL B.V. with $220.8M.

How can I find verified Indian pharmaceutical suppliers for Netherlands?

TransData Nexus covers 120 active exporters with shipment history and trade values at transdatanexus.com.

Netherlands to India Pharmaceutical Import (2026) — $232.7M, 120 Foreign Suppliers | TransData Nexus

Q: What certifications do Indian pharmaceutical exporters need to supply Netherlands?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

Netherlands to India Pharmaceutical Import (2026) — $232.7M, 120 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Netherlands to India

#	Formulation	Value	Share
1	Vaccine	$215.4M	92.6%
2	Plasma	$5.9M	2.5%
3	Serum	$4.7M	2.0%
4	Amphotericin	$2.0M	0.9%
5	Ustekinumab	$1.5M	0.6%
6	Protein	$509.0K	0.2%
7	Pomalidomide	$304.3K	0.1%
8	Cladribine	$243.9K	0.1%
9	Iron	$234.3K	0.1%
10	Fludarabine	$230.8K	0.1%
11	Posaconazole	$160.3K	0.1%
12	Cabozantinib	$134.4K	0.1%
13	Trastuzumab	$132.1K	0.1%
14	Pembrolizumab	$115.8K	0.0%
15	Paclitaxel	$99.9K	0.0%

India imports 20+ pharmaceutical formulations from Netherlands with a combined trade value of $232.7M. Key products include Vaccine ($215.4M), Plasma ($5.9M), Serum ($4.7M), Amphotericin ($2.0M), Ustekinumab ($1.5M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,546 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Netherlands to India Trade Routes

1Vaccine$215.4M

2Plasma$5.9M

3Serum$4.7M

4Amphotericin$2.0M

5Ustekinumab$1.5M

6Protein

Top Netherlands Suppliers to India

1Intervet International B.v.

$220.8M

2Intervet International B V

$2.1M

3Janssen Pharmaceutica N.v.

$1.2M

4Merck Sharp & Dohme Asia Pacific Services Pte Ltd

$583K

5Bilthoven Biologicals B.v.

$463K

Trade Statistics

Total Value$232.7M

Shipments1,546

Indian Exporters120

Netherlands Buyers95

Avg Shipment$151K

Products115

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

What is the total value of India's pharmaceutical export to Netherlands?

India exported pharmaceuticals worth $232.7M to Netherlands across 1,546 verified shipments.

Who are the top Indian pharmaceutical exporters to Netherlands?

1. INTERVET INTERNATIONAL B.V. — $220.8M. 2. INTERVET INTERNATIONAL B V — $2.1M. 3. JANSSEN PHARMACEUTICA N.V. — $1.2M. Total: 120 suppliers.

Which companies in Netherlands import pharmaceuticals from India?

1. INTERVET INDIA PRIVATE LIMITED — $222.8M. 2. INTERVET INDIA PVT LTD — $1.8M. 3. JOHNSON & JOHNSON PRIVATE LIMITED — $1.2M. 95 buyers total.

What pharmaceutical products does India export most to Netherlands?

1. Vaccine ($215.4M, 92.6%); 2. Plasma ($5.9M, 2.5%); 3. Serum ($4.7M, 2.0%); 4. Amphotericin ($2.0M, 0.9%); 5. Ustekinumab ($1.5M, 0.6%)

Which ports handle pharmaceutical shipments from India to Netherlands?

Export: . Import: .

Why does Netherlands import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $232.7M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Netherlands?

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Netherlands identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,546 verified shipments from 120 Indian exporters to 95 Netherlands buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

120 Exporters

95 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Netherlands to India Pharmaceutical Import